Kenvue Inc. Common Stock vs Range Nuclear Renaissance ETF — how do they compare? Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B), while Range Nuclear Renaissance ETF trades at $61.26 (market cap $698.21M). The key difference: Kenvue Inc. Common Stock is far larger — about 48.8× Range Nuclear Renaissance ETF's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Range Nuclear Renaissance ETF pays none. Which is the better fit depends on your goals.
| KVUE | NUKZ | |
|---|---|---|
Market Cap | $34.06B | $698.21M |
Volume | 23,267,228 | 57,444 |
Sector | Consumer Staples | Sector/Thematic |
52-Week High | $19.83 | $76.23 |
52-Week Low | $14.11 | $60.23 |
Enterprise Value | $41.56B | — |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 18 Days |
Trailing returns across standard periods
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →Range Nuclear Renaissance ETF seeks to track companies related to the nuclear energy industry. Its holdings may include businesses involved in uranium, nuclear power generation, reactors, and nuclear services.
Read more on NUKZ →